Adamax
Adamantane-modified nootropic peptide: Adamax is meant to reach the brain more easily and is studied in animal models for memory and neuroprotection.
Not in the range right now. Leave your email and we tell you when it is back.
Overview
Adamax is a synthetic peptide with an adamantane group attached. This cage-shaped hydrocarbon makes molecules more fat-soluble; for a peptide that mainly means crossing the blood-brain barrier more easily and staying in the body for longer. Adamax was developed for experimental setups around cognition and nerve cell protection.
What the preclinical literature describes:
- modulation of cholinergic and glutamatergic signalling in the central nervous system
- effects on learning and memory performance in ageing models in animals
- neuroprotective effects in models of oxidative stress
- a comparatively long half-life and good availability in the brain, both consequences of the adamantane modification
That adamantane-modified peptides can improve learning and memory in the mouse model and promote neurogenesis as well as synaptic plasticity has been described for this class of substances since 2010.
The overall picture is more sober than with the classics: Adamax is young, and the data on the peptide itself are thin. It is usually measured against Selank and Semax, the two Russian nootropics with decades of literature behind them. That comparative literature shows how far the characterization of Adamax still lags: for Selank there are transcriptome data on the hippocampus, a clinical trial in generalized anxiety disorder and work on BDNF regulation; for Adamax there is nothing comparable. Anyone working with the substance is working with a peptide whose mechanism is plausible but only thinly documented.
Risk notes
Adamax is described as well tolerated in the available reports, but its characterization stays well behind Selank and Semax, and that shapes every statement about safety. What you should keep in mind:
- Application site: with subcutaneous or nasal dosing, mild redness or irritation is the most common observation.
- Neurotransmitters: the peptide reaches into cholinergic and glutamatergic systems, which are central signalling pathways.
- Long duration: the adamantane group extends the half-life; what acts longer is also harder to steer.
- Data situation: there is little on the peptide itself, and human studies and long-term data are missing.
This summary is no substitute for medical advice.
Sources
- Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice - shows better learning and memory performance plus more neurogenesis and synaptic plasticity in mice for adamantane-modified neurotrophic peptides.
- Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank - comparative literature on Selank: gene expression in hippocampus and spleen after single and repeated dosing.
- Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank - comparative literature on Selank: clinical study on response in generalized anxiety disorder.
All products are intended for in-vitro research and laboratory use only. Not for human or veterinary use, not for diagnosis or treatment. The texts summarise published research and are no medical advice.